SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2017)
SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.89 Bn | 1.78 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -45.58% |
| Jun 30, 2017 | -42.86% |
| Mar 31, 2017 | -42.14% |
| Dec 31, 2016 | -40.60% |
| Sep 30, 2016 | -21.53% |
| Jun 30, 2016 | -51.32% |
| Mar 31, 2016 | -43.37% |
| Dec 31, 2015 | 17.54% |
| Sep 30, 2015 | -51.10% |
| Jun 30, 2015 | -14.61% |
| Mar 31, 2015 | -19.14% |
| Dec 31, 2014 | -57.14% |
| Sep 30, 2014 | 8.07% |
| Jun 30, 2014 | 33.40% |
| Mar 31, 2014 | 2,318.52% |
| Dec 31, 2013 | 2,193.10% |
| Sep 30, 2013 | 1,658.06% |
| Mar 31, 2013 | -92.31% |
| Dec 31, 2012 | -92.62% |
| Sep 30, 2012 | -92.79% |